CLINICAL_TRIALS
trial_result
· 2016-09-13
Clinical Trial Update: Changes in Lipids and Lipoproteins in HIV Infected Women After Switch From Protease Inhibitor to Raltegravir [Phase 2]
Summary
A Phase 2 trial in HIV-infected women found changes in lipid and lipoprotein levels after switching from a protease inhibitor to raltegravir.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Arbeitsgemeinschaft medikamentoese Tumortherapie | Conditions: HIV Infections | Phase 2 | Status: COMPLETED | Results posted: 2016-09-13